Clinically, elevated CD73 levels in the tumor tissue of several cancer types, including breast, ovarian, and colorectal cancers (CRC), are linked to poor patient survival7–9, which underscores the crucial role of CD73 in tumor progression. The gene discussed is NT5E; the disease is colorectal carcinoma.